Ezra Y. Rosen

3.2k total citations · 1 hit paper
32 papers, 924 citations indexed

About

Ezra Y. Rosen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ezra Y. Rosen has authored 32 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ezra Y. Rosen's work include DNA Repair Mechanisms (8 papers), Cancer Genomics and Diagnostics (8 papers) and Lung Cancer Treatments and Mutations (5 papers). Ezra Y. Rosen is often cited by papers focused on DNA Repair Mechanisms (8 papers), Cancer Genomics and Diagnostics (8 papers) and Lung Cancer Treatments and Mutations (5 papers). Ezra Y. Rosen collaborates with scholars based in United States, United Kingdom and Canada. Ezra Y. Rosen's co-authors include Alexander Drilon, Jaclyn F. Hechtman, Ryma Benayed, David M. Hyman, James P. Solomon, Denise Frosina, Marc Ladanyi, Kerry Mullaney, Achim A. Jungbluth and Irina Linkov and has published in prestigious journals such as Nature Communications, Neuron and Journal of Clinical Oncology.

In The Last Decade

Ezra Y. Rosen

27 papers receiving 900 citations

Hit Papers

NTRK fusion detection across multiple assays and 33,997 c... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
    2019 366 citations James P. Solomon, Irina Linkov et al. Modern Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ezra Y. Rosen United States 10 381 328 299 192 177 32 924
Kerry Mullaney United States 13 501 1.3× 670 2.0× 463 1.5× 362 1.9× 76 0.4× 24 1.5k
Marjolijn C.J. Jongmans Netherlands 24 295 0.8× 426 1.3× 868 2.9× 172 0.9× 468 2.6× 69 1.8k
Anna F. Lee Canada 16 279 0.7× 384 1.2× 433 1.4× 96 0.5× 37 0.2× 44 1.1k
Ana Novokmet Canada 11 472 1.2× 193 0.6× 582 1.9× 444 2.3× 355 2.0× 15 1.3k
Surya P. Rednam United States 11 139 0.4× 132 0.4× 322 1.1× 169 0.9× 150 0.8× 31 766
Barbara Padberg Switzerland 13 291 0.8× 140 0.4× 191 0.6× 197 1.0× 67 0.4× 21 918
Aniello Cerrato Italy 24 668 1.8× 240 0.7× 957 3.2× 325 1.7× 163 0.9× 33 1.7k
Naomi L. Bowers United Kingdom 21 215 0.6× 172 0.5× 557 1.9× 172 0.9× 208 1.2× 38 1.4k
Oskar Koperek Austria 24 314 0.8× 140 0.4× 299 1.0× 143 0.7× 108 0.6× 44 1.3k
A. Jayne Crew United Kingdom 11 462 1.2× 778 2.4× 620 2.1× 100 0.5× 184 1.0× 11 1.4k

Countries citing papers authored by Ezra Y. Rosen

Since Specialization
Citations

This map shows the geographic impact of Ezra Y. Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezra Y. Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezra Y. Rosen more than expected).

Fields of papers citing papers by Ezra Y. Rosen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ezra Y. Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezra Y. Rosen. The network helps show where Ezra Y. Rosen may publish in the future.

Co-authorship network of co-authors of Ezra Y. Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Ezra Y. Rosen. A scholar is included among the top collaborators of Ezra Y. Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ezra Y. Rosen. Ezra Y. Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vieito, María, Ezra Y. Rosen, Jordi Rodón, et al.. (2024). 612O Preliminary results from a phase I study of CFT1946, a novel BIDAC degrader in mutant BRAF V600 solid tumors. Annals of Oncology. 35. S490–S491. 3 indexed citations
3.
Fontana, Elisa, Ezra Y. Rosen, Elizabeth K. Lee, et al.. (2024). Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study). JNCI Journal of the National Cancer Institute. 116(9). 1439–1449. 7 indexed citations
4.
5.
Desîlets, Antoine, Matteo Repetto, Monica F. Chen, et al.. (2024). Abstract 6568: PTCH1 loss-of-function alterations: Mutational landscape and therapeutic outcomes to hedgehog pathway inhibitors in non-canonical histologies. Cancer Research. 84(6_Supplement). 6568–6568.
6.
Carneiro, Benedito A., Ezra Y. Rosen, Elisa Fontana, et al.. (2024). 619MO Camonsertib (cam) monotherapy in patients (pts) with advanced cancers harboring ATM loss-of-function (LoF). Annals of Oncology. 35. S496–S496.
7.
8.
Rosen, Ezra Y., Timothy A. Yap, Elizabeth K. Lee, et al.. (2023). Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib. Clinical Cancer Research. 30(4). 687–694. 4 indexed citations
9.
Silverman, Ian M., Joseph D. Schonhoft, Arielle Yablonovitch, et al.. (2023). Performance of Circulating Tumor DNA (ctDNA) Genomic and Epigenomic Profiling (GuardantINFINITY) in the TRESR and ATTACC Studies. SHILAP Revista de lepidopterología. 1. 100014–100014. 1 indexed citations
10.
Repetto, Matteo, Allison L. Richards, Monica F. Chen, et al.. (2023). MYC amplification segment-size mutual exclusivity analysis with other oncogenic events in a pan-cancer sequencing cohort.. Journal of Clinical Oncology. 41(16_suppl). 3073–3073. 1 indexed citations
11.
12.
Rosen, Ezra Y., Alexander Drilon, & Debyani Chakravarty. (2022). Precision Oncology: 2022 in Review. Cancer Discovery. 12(12). 2747–2753. 6 indexed citations
13.
Murciano‐Goroff, Yonina R., Alison M. Schram, Ezra Y. Rosen, et al.. (2022). Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies. Nature Communications. 13(1). 7182–7182. 19 indexed citations
14.
Harada, Guilherme, Noura J. Choudhury, Alison M. Schram, et al.. (2022). Mechanisms of acquired resistance to TRK inhibitors.. Journal of Clinical Oncology. 40(16_suppl). 3104–3104. 11 indexed citations
15.
Yang, Soo‐Ryum, Umut Aypar, Ezra Y. Rosen, et al.. (2020). A Performance Comparison of Commonly Used Assays to Detect RET Fusions. Clinical Cancer Research. 27(5). 1316–1328. 50 indexed citations
16.
Rosen, Ezra Y., Debra A. Goldman, Jaclyn F. Hechtman, et al.. (2019). TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations. Clinical Cancer Research. 26(7). 1624–1632. 115 indexed citations
17.
Solomon, James P., Irina Linkov, Kerry Mullaney, et al.. (2019). NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Modern Pathology. 33(1). 38–46. 366 indexed citations breakdown →
18.
Rosen, Ezra Y., Alison M. Schram, Robert J. Young, et al.. (2019). Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors. JCO Precision Oncology. 3(3). 1–5. 21 indexed citations
19.
Rosen, Ezra Y., Eric Wexler, Giovanni Coppola, et al.. (2011). Functional Genomic Analyses Identify Pathways Dysregulated by Progranulin Deficiency, Implicating Wnt Signaling. Neuron. 71(6). 1030–1042. 100 indexed citations
20.
Eisen, Andrea, Jan Lubiński, J. Gronwald, et al.. (2008). Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers. JNCI Journal of the National Cancer Institute. 100(19). 1361–1367. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kerry Mullaney Breakdown of academic impact, for papers by Marjolijn C.J. Jongmans Breakdown of academic impact, for papers by Anna F. Lee Breakdown of academic impact, for papers by Ana Novokmet Breakdown of academic impact, for papers by Surya P. Rednam Breakdown of academic impact, for papers by Barbara Padberg Breakdown of academic impact, for papers by Aniello Cerrato Breakdown of academic impact, for papers by Naomi L. Bowers Breakdown of academic impact, for papers by Oskar Koperek Breakdown of academic impact, for papers by A. Jayne Crew
Rankless by CCL
2026